Clinicians managing pediatric HSCT inpatients estimate 58% develop sleep issues, and they most commonly implement patient-level interventions like melatonin despite rating external factors like noise as most impactful.
A survey of 111 pediatric HSCT clinicians (prescribers, nurses, psychosocial staff) across the US found they estimate 58% of inpatients develop sleep issues. Although clinicians rated external factors (e.g., noise) as most impactful, they were most likely to implement patient-level interventions such as melatonin. The study highlights the lack of clinical guidelines and the need for research on treatment efficacy and systems-level changes.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Clinicians managing pediatric HSCT inpatients estimate 58% develop sleep issues, and they most commonly implement patient-level interventions like melatonin despite rating external factors like noise as most impactful. The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 32/100 (low).
The Claim
Clinicians managing pediatric HSCT inpatients estimate 58% develop sleep issues, and they most commonly implement patient-level interventions like melatonin despite rating external factors like noise as most impactful.
This conclusion is most relevant to: 111 pediatric HSCT medical prescribers, nurses, and psychosocial staff from across the United States.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸How Clinicians Manage Sleep During Inpatient Hospitalization Following Pediatric Hematopoietic Stem Cell Transplantation. (Pediatric blood & cancer, 2026) —
How It Works
The proposed biological pathway:
- ▸Clinicians observe sleep disruptions in pediatric HSCT inpatients
- ▸They rate external factors (e.g., noise) as most impactful
- ▸Despite this, they most often implement patient-level interventions (e.g., melatonin)
- ▸Result: Gap between perceived cause and chosen intervention, indicating need for systems-level changes
Who Might Benefit
Evidence fit by population:
- ▸111 pediatric HSCT medical prescribers, nurses, and psychosocial staff from across the United States
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Survey-based, relying on clinician estimates rather than objective sleep measures
- ▸No data on actual efficacy of melatonin or other interventions in this population
- ▸Limited generalizability as sample may not represent all pediatric HSCT centers
Frequently Asked Questions
What percentage of pediatric HSCT inpatients develop sleep issues according to clinicians?▼
Clinicians estimated that 58% of inpatients develop sleep issues.
What interventions do clinicians most commonly use for sleep disruptions in pediatric HSCT patients?▼
Clinicians most commonly implement patient-level interventions, such as melatonin.
What did clinicians identify as the most impactful factor for sleep disruptions?▼
Clinicians rated external factors, such as noise, as most impactful.
What does the study recommend for future research?▼
The study recommends assessing the efficacy of commonly delivered treatments and developing systems-level changes to address external sleep barriers.
References
- 1.Chevalier L, Robinson E, Weller E, Klett MK, Daniel LC, Crabtree VM, Mintor R, Blacken R, Tarquini S, Schoettler ML, Fidler AL, Warren EAH, Rosenberg AR, Lehmann LE, Zhou ES. “How Clinicians Manage Sleep During Inpatient Hospitalization Following Pediatric Hematopoietic Stem Cell Transplantation..” Pediatric blood & cancer, 2026. PMID: 42527970 DOI: 10.1002/1545-5017.70468